<--- Back to Details
First PageDocument Content
Medicine / Neurochemistry / Clinical medicine / RTT / General anesthetics / Dosage forms / Calcium channel blockers / Sodium channel blockers / Ketamine / Adverse effect / Intravenous therapy / FOLFOX
Medicine
Neurochemistry
Clinical medicine
RTT
General anesthetics
Dosage forms
Calcium channel blockers
Sodium channel blockers
Ketamine
Adverse effect
Intravenous therapy
FOLFOX

Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

Add to Reading List

Source URL: www.medicines.org.uk

Download Document from Source Website

File Size: 89,06 KB

Share Document on Facebook

Similar Documents

Beilage 1: Arzneimittelmonographien

Beilage 1: Arzneimittelmonographien

DocID: 1rinj - View Document

Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

DocID: 1reFq - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ORENITRAM® safely and effectively. See Full Prescribing Information for ORENITRAM.  --------------------- DOSAGE FO

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ORENITRAM® safely and effectively. See Full Prescribing Information for ORENITRAM. --------------------- DOSAGE FO

DocID: 1rcHl - View Document

Strensiq, INN-asfotase alfa

Strensiq, INN-asfotase alfa

DocID: 1rcrc - View Document

Microsoft Word - CINRYZE.Product Monographdoc

Microsoft Word - CINRYZE.Product Monographdoc

DocID: 1qE2h - View Document